Neurosurg Focus 39 (3):E5, 2015 P eriPheral nerve tumors are not uncommon. Schwannomas and neurofibromas, for instance, each account for 5% of all soft-tissue tumors.
Since the late 1980s, 10 the application of ultrasound in soft tissues has played an important role. Focusing on peripheral nerves, high-resolution ultrasound (HRU) is mainly applied in the preoperative workup of nerve entrapment and trauma. For traumatic lesions, nerve transection or hemorrhage is safely depicted by ultrasound, which enables nerve surgeons to perform nerve reconstruction earlier than ever before. 11 In 2011, our study group examined traumatic nerve lesions in an intraoperative setting by using the full technical capacity of HRU with its very high spatial resolution and tissue-differentiating properties. 12 By this means, the nerve is externally neurolyzed and embedded between 2 ultrasound gel cushions, and the transducer is set directly on the nerve segment to be evaluated. This technique enables the surgeon to see directly into the fascicular structure and epineurium.
Furthermore, the technique of contrast-enhanced ultrasound (CEUS) was developed as a tool for differentiating benign and malignant pathologies in the liver or kidney. 1, 22 In the present study, we investigated intraoperative HRU and CEUS (iHRU and iCEUS, respectively) with regard to the question of whether these techniques have the potential to help the surgeon to distinguish different peripheral nerve tumors and tumorlike lesions.
methods
From May 2010 to October 2014, a total of 161 patients underwent surgery for peripheral nerve tumors in our department. As part of the preoperative diagnostic workup, each patient underwent MRI, and if malignancy was suspected, additional FDG PET and PET CT scans were performed. In 13 cases (8%), this preoperative workup revealed "atypical" signs of nerve tumors, meaning that the tumors were something other than schwannoma or neurofibroma. To gain further morphological knowledge in those cases, iHRU was performed.
The intraoperative ultrasound examination (iU22, Philips Medical Systems) was carried out using a sterilely draped small-footprint 15-to 7-MHz ( Fig. 1 upper and lower) or alternatively a 17-to 5-MHz linear array ultrasound transducer. Depending on their properties in iHRU, groups of ultrasound patterns were defined and correlated to the final histopathological diagnosis. In 3 cases, additional iCEUS was applied to study tumor perfusion using a 12-MHz probe. As a contrast medium, 1 ampule of SonoVue (Bracco Imaging) with 5 ml saline solution was administered intravenously.
Results
The study group consisted of 7 male and 6 female patients ranging in age from 23 months to 56 years (mean age 36 years). Histopathological results were available an average of 3-7 days after surgery. (Table 1) . Reference pathology was performed in 4 cases (for the patients with LSS or MPNST). The examination took up to 5 minutes to determine the respective perfusion pattern of each tumor ( Table 2) .
Excluding the patients with an MPNST, each patient had paresthesia and slowly progressing palsy in the distribution of the respective nerve.
Depending on their ultrasonographic peculiarities in iHRU, 3 different ultrasound patterns were found in the study group, and each was assigned to 1 of the following 3 different pathological descriptions: 1) hypoechoic, enlarged fascicles (perineurioma, amyloidoma, LSS) (Group A); 2) dense, giant fascicles (B-cell lymphoma) (Group B); or 3) no fascicle structure distinguishable, irregular mass, cystic, hypoechoic or isoechoic to hyperechoic parts (MPNST, ancient schwannoma, SFT) (Group C).
group A: perineurioma, Amyloidoma, and lSS
Although of different origins and pathologies, perineurioma, amyloidoma, and LSS resembled each other in iHRU; the nerves' cross-sections were markedly enlarged and contained large, thickened hypoechogenic fascicles. The epineuria appeared normal. On closer examination, subtle details distinguished the different entities from each other (Figs. 2-4 ): in cases of perineurioma and amyloidoma, hypoechogenic enlarged fascicles were detected throughout the entire cross-section of each nerve, and in cases of LSS, normal fascicles were detected beneath the hypoechogenic and enlarged fascicular structures.
group B: B-cell lymphoma
The ultrasound pattern in Group B was exceptional: the nerve exhibited a marked cross-sectional enlargement, and the epineurium appeared to be normal. The fascicular structures were markedly enlarged, dense, and hyperechogenic, with hypoechogenic septae subdividing the fascicle groups.
This unusual sciatic nerve tumor at the midthigh level became symptomatic, with slowly progressive paresis including foot elevation and flexion and paresthesia of the sole and dorsal thigh. During surgery after exposure of the nerve and ultrasound, we decided to open the epineurium and perform a biopsy of a conspicuous fascicle. The fascicles appeared to be transparent ( Fig. 5A-D) . Histopathological diagnosis revealed B-cell lymphoma. After oncological staging, it turned out to be the solitary manifestation of B-cell lymphoma in that female patient. Radiotherapy was performed, but she refused additional chemotherapy; 2.5 years after diagnostic identification, the patient was still alive.
group c: mpNST, Ancient Schwannoma, and SFT
Although in their preoperative imaging, all lesions in this group showed similarities, such as positive contrast enhancement in MRI (T1-weighted sequence) and irregular tumor masses in HRU, this group of lesions turned out to be inhomogeneous in their particular histopathological results. Intraoperative ultrasound revealed loss of fascicular structure combined with cystic formations for each of them. The tumor masses consisted of adjacent areas of isoechoic, hypoechoic, and hyperechoic tissue (see an example of an MPNST in Fig. 6 ).
In the synopsis of the findings, suspicion of potential malignancy was indicated for each of the patients in this group (n = 5). With the objective of further improving tis- sue differentiation, iCEUS was applied in 3 of these patients. Thus far, the only available contrast medium, SonoVue, is officially approved only for mammary and liver ultrasound. In peripheral nerve tumors, its use until now has been considered off label. As part of individualized treatment, we used CEUS after the written consent of each patient was obtained. The first patient (Table 1 , Patient 11), who had a slowly growing mass in his lower leg, had minimal neurological deficit. The tumor arose from the tibial nerve. The second patient, who had a brachial plexus tumor (Table 1 , Patient 12), suffered from pain radiating into his left upper arm under strain (Fig. 7A-F) .
The last case (Table 1, Patient 13) was of a young woman suffering from neurofibromatosis Type 1 (NF-1) with a tumor mass involving her sciatic nerve in the thigh. That lesion has been surgically treated 2 years earlier. Histopathology revealed MPNST. She refused any adjuvant therapy after the first surgery. In the summer of 2014, she developed a fast-growing recurrence and underwent further resection ( Fig. 8 upper and lower) .
Comparing this last NF-1 case (Patient 13) with that of a brachial plexus tumor (Patient 12), the iHRU images seemed very similar. Moreover, both cases showed positive perfusion patterns on iCEUS images. However, the time to peak perfusion differed markedly in both lesions: 19 seconds in the MPNST case and more than 1 minute in the brachial plexus tumor. Histopathology revealed ancient schwannoma (WHO Grade I) in the patient with the brachial plexus tumor and recurrent MPNST in the NF-1 case.
The other case (Patient 11) resulted in identification of an extrapleural SFT of the tibial nerve, which was classified as French Fédération Nationale des Centres de Lutte Contre le Cancer Grade II. The tumor did not show any perfusion pattern in the iCEUS images.
discussion
To our knowledge, this is the first study to use iHRU for tumors and tumorlike nerve lesions. As Rodriguez et al. 17 already pointed out in their pathological study, the differential diagnosis of these pathologies is difficult and controversial. Because we gained positive experience with the tissue-differentiating properties of iHRU in traumatic nerve lesions, 12 we decided to apply this technique to tumors and tumorlike lesions of peripheral nerves.
In our limited experience with 13 patients, 3 different patterns have been distinguished in iHRU images so far.
group A (hypoechoic, Enlarged Fascicles)
Hypoechoic swollen fascicles are frequently found in peripheral nerve lesions, mostly in cases of nerve entrapment. 11 In Group A, we found this pattern in perineuriomas, in amyloidomas, and in 1 case of MADSAM. In our preliminary experience so far, no definitive differentiation between those 3 entities was possible with iHRU. However, a subtle difference between perineuriomas and amyloidomas and MADSAM was noticed: in perineuriomas and amyloidomas, hypoechogenic and enlarged fascicles took up the complete cross-sectional area of the nerve, whereas with MADSAM, normal fascicles were detected beneath those hypoechogenic and enlarged fascicular structures. This interesting finding points toward the multifocal nature of lesion dispersion in this inflammatory neuropathy.
group B (dense, giant Fascicles)
The iHRU pattern of dense giant fascicles was detected in 1 patient and did not resemble any other ultrasound pattern seen before by us. This ultrasound finding was seen on images of a patient with a very rare entity scarcely described in the literature so far:
8 primary B-cell lymphoma involving the sciatic nerve. Similar to a description by Descamps et al., 8 MRI of this patient revealed a contrast-enhancing edematous lesion of the sciatic nerve that resembled a perineurioma or amyloidoma. Intraoperative findings and iHRU revealed a unique pathology, well distinguishable from that of all other tumor entities. In a recent study, Capek et al. 6 described another case of a diffuse large B-cell lymphoma of the sciatic nerve examined by ultrasound. Similar to our findings, nerve fascicles were preserved but enlarged and infiltrated by the hematological disease.
group c (No Fascicle Structure distinguishable, Irregular mass, cystic)
This group turned out to be very inhomogeneous. Despite its spatial high resolution with good tissue-differentiating properties, HRU alone was not capable of differentiating pathologies, particularly benign and malignant peripheral nerve tumors.
To acquire more knowledge about potential malignant nerve tumors, we decided to apply SonoVue (Bracco Imaging) as a contrast agent for ultrasonography performed in this study. In 2002, Bodner et al. 3 proved that additional ultrasound tools such as power Doppler and spectral wave analysis improve the differentiation of malignant and benign musculoskeletal tumors by depicting their vascular architecture. In 2012, Loizides et al.
14 used CEUS to examine 54 patients with musculoskeletal masses. An irreg- ular positive perfusion pattern, which was determined as Type P2 or P3, indicated a high probability of malignancy. Concerning nerve tumors, there was just 1 case of schwannoma with a positive Type P4 perfusion pattern, which was a sign of benignity. Because of the low differentiating properties of ultrasound, especially in Group C, we decided to apply CEUS to explore its capability for enhancing the differential diagnostic distinction. iCEUS was applied in 3 cases: 1 of ancient schwannoma, 1 of SFT, and 1 of MPNST. Although the SFT did not show any perfusion at all, the perfusion pattern of benign cystic schwannoma very much resembled that of the MPNST. However, the time to peak (the time from injection of the contrast agent to its detection) differed significantly between the degenerative modified ancient schwannoma and the MPNST. The MPNST had a very short time to peak.
These results agree with those of many publications regarding ultrasound of other organs (e.g., liver), indicating that, beneath the spatial pattern of perfusion, the temporal course serves as a valuable discriminator. In 2009, a group from Verona, Italy, showed positive enhancement in the arterial phase by examining nonfunctioning pancreatic neuroendocrine tumors. CEUS revealed a rapid positive perfusion pattern in 63.1% of their patients. Moreover, these results correlated with a positive Ki-67 index and the existence of hepatic metastasis. 15 After the first results in breast tumors, the application of CEUS was not pathbreaking for the identification of malignancy.
2 Therefore, in 2011, CEUS was not recommended in the European Federation of Societies for Ultrasound in Medicine and Biology guidelines 16 for the examination of mamma carcinoma. Meanwhile, in the latest studies from 2014, a correlation between CEUS characteristics and prognostic factors for breast cancer was detected. 
conclusions
Multimodal ultrasound seems to be a promising diagnostic tool in the diagnostic differentiation of peripheral nerve tumors and tumorlike lesions. Additional systematic studies are necessary to characterize and differentiate these different pathologies. 
